Association between uremic toxins and depression in patients with chronic kidney disease undergoing maintenance hemodialysis

General Hospital Psychiatry

Volumn 35, Issue 1, 2013, Pages 23-27

  Hsu, Heng Jung ^a,b,c   Yen, Chiung Hui ^d   Chen, Chih Ken ^a,b   Wu, I Wen ^a,b   Lee, Chin Chan ^a,b   Sun, Chiao Yin ^a,b   Chang, Shu Ju ^a   Chou, Chia Chi ^a,b   Hsieh, Ming Fang ^a,b   Chen, Chun Yu ^a,b   Hsu, Chiao Ying ^a,b   Tsai, Chi Jen ^a,b   Wu, Mai Szu ^a,b,c,d,e  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

2 Microglobulin; Chronic kidney disease; Depression; Hemodialysis; Indoxyl sulfate; P Cresol sulfate

Indexed keywords

BETA 2 MICROGLOBULIN; INDICAN; PARA CRESOL; UREA;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BIOACCUMULATION; BODY MASS; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; UREMIA;

ADULT; AGED; BETA 2-MICROGLOBULIN; BODY MASS INDEX; COHORT STUDIES; CREATININE; CRESOLS; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; INDICAN; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; RENAL DIALYSIS; SERUM ALBUMIN; SULFURIC ACID ESTERS; UREA; UREMIA;

EID: 84872377422     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2012.08.009     Document Type: Article

References (32)

1. Weissman M.M., Bland R.C., Canino G.J., et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996, 276(4):293-299.
2. Foster F.G., Cohn G.L., McKegney F.P. Psychobiologic factors and individual survival on chronic renal hemodialysis. A two year follow-up: I. Psychosom Med 1973, 35(1):64-82.
3. Hedayati S.S., Jiang W., O'Connor C.M., et al. The association between depression and chronic kidney disease and mortality among patients hospitalized with congestive heart failure. Am J Kidney Dis 2004, 44(2):207-215.
4. Agganis B.T., Weiner D.E., Giang L.M., et al. Depression and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis 2010, 56(4):704-712.
5. Kimmel P.L., Weihs K., Peterson R.A. Survival in hemodialysis patients: the role of depression. J Am Soc Nephrol 1993, 4(1):12-27.
6. Kimmel P.L., Peterson R.A., Weihs K.L., et al. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int 2000, 57(5):2093-2098.
7. Lopes A.A., Bragg J., Young E., et al. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int 2002, 62(1):199-207.
8. Young B.A., Von Korff M., Heckbert S.R., et al. Association of major depression and mortality in Stage 5 diabetic chronic kidney disease. Gen Hosp Psychiatry 2010, 32(2):119-124.
9. Sullivan P.F., Neale M.C., Kendler K.S. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000, 157(10):1552-1562.
10. Polsky D., Doshi J.A., Marcus S., et al. Long-term risk for depressive symptoms after a medical diagnosis. Arch Intern Med 2005, 165(11):1260-1266.
11. Maes M., Meltzer H.Y., Bosmans E., et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 1995, 34(4):301-309.
12. 12, folate, and homocysteine in depression: the Rotterdam Study. Am J Psychiatry 2002, 159(12):2099-2101.
13. Chilcot J., Wellsted D., Da Silva-Gane M., et al. Depression on dialysis. Nephron Clin Pract 2008, 108(4):c256-c264.
14. Drey N., Roderick P., Mullee M., et al. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 2003, 42(4):677-684.
15. Lindner A., Charra B., Sherrard D.J., et al. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974, 290(13):697-701.
16. Vanholder R., Glorieux G., De Smet R., et al. New insights in uremic toxins. Kidney Int Suppl 2003, 84:S6-S10.
17. Vanholder R., Glorieux G., Lameire N. New insights in uremic toxicity. Contrib Nephrol 2005, 149:315-324.
18. Atoh K., Itoh H., Haneda M. Serum indoxyl sulfate levels in patients with diabetic nephropathy: relation to renal function. Diabetes Res Clin Pract 2009, 83(2):220-226.
19. Bammens B., Evenepoel P., Keuleers H., et al. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 2006, 69(6):1081-1087.
20. Wu I.W., Hsu K.H., Hsu H.J., et al. Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients--a prospective cohort study. Nephrol Dial Transplant 2012, 27(3):1169-1175.
21. Olsson I., Mykletun A., Dahl A.A. The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 2005, 5:46.
22. Loosman W.L., Siegert C.E., Korzec A., et al. Validity of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory for use in end-stage renal disease patients. Br J Clin Psychol 2010, 49(Pt 4):507-516.
23. Audrain-McGovern J., Lerman C., Wileyto E.P., et al. Interacting effects of genetic predisposition and depression on adolescent smoking progression. Am J Psychiatry 2004, 161(7):1224-1230.
24. Schaefer F., Vogel M., Kerkhoff G., et al. Experimental uremia affects hypothalamic amino acid neurotransmitter milieu. J Am Soc Nephrol 2001, 12(6):1218-1227.
25. Vanholder R., De Smet R., Glorieux G., et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003, 63(5):1934-1943.
26. Niwa T., Nomura T., Sugiyama S., et al. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Kidney Int Suppl 1997, 62:S23-S28.
27. Gelasco A.K., Raymond J.R. Indoxyl sulfate induces complex redox alterations in mesangial cells. Am J Physiol Renal Physiol 2006, 290(6):F1551-F1558.
28. Shimizu H., Hirose Y., Nishijima F., et al. ROS and PDGF-beta [corrected] receptors are critically involved in indoxyl sulfate actions that promote vascular smooth muscle cell proliferation and migration. Am J Physiol Cell Physiol 2009, 297(2):C389-C396.
29. Barreto F.C., Barreto D.V., Liabeuf S., et al. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 2009, 4(10):1551-1558.
30. Li Z.J., An X., Mao H.P., et al. Association between depression and malnutrition-inflammation complex syndrome in patients with continuous ambulatory peritoneal dialysis. Int Urol Nephrol 2011, 43(3):875-882.
31. Young S.N., Gauthier S. Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1981, 44(4):323-328.
32. Wurtman R.J., Hefti F., Melamed E. Precursor control of neurotransmitter synthesis. Pharmacol Rev 1980, 32(4):315-335.